Back to Search
Start Over
Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause
- Source :
- Przegla̜d Menopauzalny = Menopause Review, Menopause Review, Vol 19, Iss 4, Pp 195-199 (2021)
- Publication Year :
- 2020
- Publisher :
- Termedia Sp. z.o.o., 2020.
-
Abstract
- During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep. The symptoms of vulvovaginal atrophy are especially troublesome for menopausal women. These symptoms not only disturb the sexual sphere, but also functioning at work and in the family. Based on the literature, a review of contemporary methods of management in the case of symptoms of vulvar atrophy in menopausal women has been performed. The current methods of treating vulvovaginal atrophy in menopausal women are described. The pharmacology of the available dehydroepiandrosterone (DHEA) preparations, both oral and vaginal, was briefly analyzed. Own experiences of using DHEA are presented. Vaginal DHEA has been found to be an effective and safe treatment in menopausal women with symptoms of vaginal atrophy.
- Subjects :
- medicine.medical_specialty
Obstetrics
medicine.drug_class
business.industry
Genitourinary system
Endocrinology, Diabetes and Metabolism
menopause
Obstetrics and Gynecology
Dehydroepiandrosterone
Case Report
vulvovaginal atrophy
medicine.disease
Vulvovaginal atrophy
Menopause
Atrophy
Mood
Estrogen
medicine
Medicine
Vaginal atrophy
DHEA
business
Subjects
Details
- ISSN :
- 16438876
- Volume :
- 19
- Database :
- OpenAIRE
- Journal :
- Menopausal Review
- Accession number :
- edsair.doi.dedup.....ea530ee698d79666fd878937c5266cb6